Weight stabilisation is associated with improved survival duration and quality of life in unresectable pancreatic cancer

被引:136
作者
Davidson, W
Ash, S
Capra, S
Bauer, J
机构
[1] Princess Alexandra Hosp, Nutr & Dietet Serv, Brisbane, Qld 4102, Australia
[2] Queensland Univ Technol, Ctr Publ Hlth Res, Brisbane, Qld, Australia
[3] Wesley Res Inst, Brisbane, Qld, Australia
关键词
nutrition; pancreatic neoplasms; cachexia; weight loss; quality of life; survival;
D O I
10.1016/j.clnu.2003.07.001
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background Et aims: Cancer-induced weight toss is associated with poor outcomes and is common in pancreatic cancer. The aims were to determine whether stabilising weight loss for patients with unresectable pancreatic cancer was associated with improved survival and quality of life (QoL) and to identify determinants of weight stabilisation. Methods: A post hoc analysis was performed using data from 107 patients in a multicentre trial. Patients were categorised as weight losing (> 1 kg lost) or weight stable (less than or equal to1 kg lost) after an 8 week nutrition intervention period. Group survival duration (Kaplan Meier) and QoL (EORTC QLQ-C30) were compared. Predictors of weight stability were determined using logistic regression analysis. Results: Patients with weight stabilisation survived longer from baseline (log rank test 5.53, P = 0.019). They also reported higher QoL scores (P = 0.037) and a greater mean energy intake (P<0.001) at Week 8 than those who continued to lose weight. The absence of nausea and vomiting (OR 6.5, P = 0.010) and female gender (OR 5.2, P = 0.020) were independent determinants of weight stabilisation. Conclusions: Weight stabilisation over an 8 week period in weight-losing patients with unresectable pancreatic cancer was associated with improved survival duration and QoL. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:239 / 247
页数:9
相关论文
共 48 条
[1]  
Aaronson N K, 1990, Oncology (Williston Park), V4, P59
[2]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[3]  
Alter CL, 1996, SEMIN ONCOL, V23, P229
[4]   Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? [J].
Andreyev, HJN ;
Norman, AR ;
Oates, J ;
Cunningham, D .
EUROPEAN JOURNAL OF CANCER, 1998, 34 (04) :503-509
[5]   The effect of an oral nutritional supplement enriched with fish oil on weight loss in patients with pancreatic cancer [J].
Barber, MD ;
Ross, JA ;
Voss, AC ;
Tisdale, MJ ;
Fearon, KCH .
BRITISH JOURNAL OF CANCER, 1999, 81 (01) :80-86
[6]  
BLACK AE, 1991, EUR J CLIN NUTR, V45, P583
[7]  
Capra Sandra, 2002, Nutr Clin Pract, V17, P210, DOI 10.1177/0115426502017004210
[9]  
Chlebowski RT, 1996, NUTRITION, V12, pS43
[10]   Current surgical therapy for carcinoma of the pancreas [J].
Cooperman, AM ;
Kini, S ;
Snady, H ;
Bruckner, H ;
Chamberlain, RS .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2000, 31 (02) :107-113